Cargando…
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment
INTRODUCTION: Methimazole (MMI) represents the conventional therapeutic agent for Graves’ disease (GD) hyperthyroidism, but MMI efficacy is limited since it marginally affects the underlying autoimmune process. In a previous study, we randomly assigned 42 newly diagnosed GD patients with insufficien...
Autores principales: | Gallo, Daniela, Bruno, Antonino, Gallazzi, Matteo, Cattaneo, Simona Antonia Maria, Veronesi, Giovanni, Genoni, Angelo, Tanda, Maria Laura, Bartalena, Luigi, Passi, Alberto, Piantanida, Eliana, Mortara, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141462/ https://www.ncbi.nlm.nih.gov/pubmed/37124743 http://dx.doi.org/10.3389/fendo.2023.1145811 |
Ejemplares similares
-
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment
por: Gallo, Daniela, et al.
Publicado: (2022) -
Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher
por: Gallo, Daniela, et al.
Publicado: (2020) -
Regulatory T Cells in the Pathogenesis of Graves’ Disease
por: Kustrimovic, Natasa, et al.
Publicado: (2023) -
Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
por: Bartalena, Luigi, et al.
Publicado: (2020) -
Change in newly diagnosed Graves’ disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression
por: Ippolito, S., et al.
Publicado: (2020)